Call to action: Finding solutions for the drug shortage crisis in the united states

Clinical Pharmacology and Therapeutics

Volumn 93, Issue 2, 2013, Pages 145-147

  Fox, E R ^a   Tyler, L S ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; GENERIC DRUG; VACCINE;

DRUG CONTROL; DRUG MANUFACTURE; DRUG QUALITY; DRUG SHORTAGE; DRUG UTILIZATION; ECONOMIC ASPECT; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE QUALITY; HUMAN; PATIENT CARE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; UNITED STATES;

DRUG INDUSTRY; DRUGS, GENERIC; HUMANS;

EID: 84872690361     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2012.225     Document Type: Review

References (10)

1. US Food and Drug Administration. A Review of FDA's Approach to Medical Product Shortages http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/ Reports/UCM277755.pdf (31 October 2011).
2. US House of Representatives, Committee on Oversight and Government Reform. FDA's contributions to the drug shortage crisis. Staff Report, US House of Representatives, 112th Congress http://oversight.house.gov/wp-content/ uploads/2012/06/6-15-2012-Report-FDAs-Contribution-to-the-Drug-Shortage-Crisis. pdf (15 June 2012).
3. Le, P. et al. The prevalence of pharmaceutical shortages in the United States. J. Generic Medicines 8, 210-218 (2011).
4. IMS Institute for Healthcare Informatics. Drug Shortages: A Closer Look at Products, Suppliers, and Volume Volatility http://www.imshealth. com/portal/site/ims/menuitem.edb2b81823f 67dab41d84b903208c22a/?vgnextoid=a6fbc c0f68f73310VgnVCM100000ed152ca2RCRD (November 2011).
5. Crosse, M. Drug shortages: FDA's Ability to Respond Should Be Strengthened. Testimony before the Committee on Health, Education, Labor, and Pensions, US Senate, US Government Accountability Office http://www.gao.gov/ products/GAO-12-315T (15 December2011).
6. US Food and Drug Administration, Center for Drug Evaluation and Research. Approach to addressing drug shortage; public workshop http://www.fda.gov/Drugs/ NewsEvents/ucm265968.htm (26 September 2011).
7. Rosoff, P.M., Patel, K.R., Scates, A., Rhea, G., Bush, P.W. & Govert, J.A. Coping with critical drug shortages: an ethical approach for allocating scarce resources in hospitals. Arch. Intern. Med. 172, 1494-1499 (2012).
8. Centers for Disease Control and Prevention. Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy-United States, 2012. MMWR. Morb. Mortal. Wkly. Rep. 61, 839-842 (2012).
9. US Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation. ASPE Issue Brief. Economic analysis of the causes of drug shortages http://aspe.hhs.gov/sp/reports/2011/DrugShortages/ ib.shtml (October 2011).
10. Woodcock, J. & Wosinska, M. Economic and technological drivers of generic sterile injectable drug shortages. Clin. Pharmacol. Ther. 93, 170-176 (2013).